right

David L. Kaplan, Ph.D.

David L. Kaplan, Ph.D.

Dr. Kaplan’s lab has pioneered the study of silk-based biomaterials in regenerative medicine, from fundamental studies of the biochemistry, molecular biology and biophysical features to their impact on stem cell functions, complex tissue formation and medical device formation.

Read More →

Read More →

Joshua Kritzer , Ph.D.

Joshua Kritzer , Ph.D.

The Kritzer lab uses peptides and peptidomimetics (peptide-like synthetic molecules) to inhibit disease-associated proteins that would be difficult or impossible to target using traditional approaches.

Read More →

Read More →

Joshua LaBaer, M.D., Ph.D.

Joshua LaBaer, M.D., Ph.D.

Joshua LaBaer is one of the nation’s foremost investigators in the rapidly expanding field of personalized diagnostics. His efforts focus on the discovery and validation of biomarkers — unique molecular fingerprints of disease — which can provide early warning for those at risk of major illnesses, including cancer and diabetes.

Read More →

Read More →

Anthony Philippakis, M.D., Ph.D.

Anthony Philippakis, M.D., Ph.D.

Dr. Philippakis has a long-standing interest in developing computational methods to analyze large collections of biological data to make predictions or discover new biology. He studied computational methods for understanding transcriptional regulation during his PhD and also contributed key methods for quality score recalibration and variant calling that are now instantiated in the Genome Analysis Toolkit. He now leads the Data Sciences Platform at the Broad Institute and focuses on creating scalable computational platforms for aggregating, analyzing and sharing genomic and clinical data.

Read More →

Read More →

Bjoern Reinhard, Ph.D.

Bjoern Reinhard, Ph.D.

Dr. Bjoern Reinhard is an expert in producing hybrid materials that combine the interesting electronic/optical properties of inorganic materials with the structural properties of biological material.

Read More →

Read More →

Victoria Seewaldt, M.D.

Victoria Seewaldt, M.D.

Dr. Victoria Seewaldt is an internationally recognized expert in biomarker development, translational research, and breast cancer initiation who leads a bench-to-community research program focusing on identifying molecular targets for early detection and biomarker development.

Read More →

Read More →

Top